Derek M Meisner Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

ABOS Quotes by TradingView

Derek M Meisner is Chief Legal Officer & Corp Sec of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 164,545 shares of ABOS, which is worth approximately $271,499. The most recent transaction as insider was on Jan 06, 2025, when has been sold 66,800 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 165K
51.14% 3M change
39.68% 12M change
Total Value Held $271,499

Derek M Meisner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2025
BUY
Grant, award, or other acquisition
-
66,800 Added 28.87%
164,545 Common Stock
Jan 03 2025
SELL
Open market or private sale
$20,464 $1.84 p/Share
11,122 Reduced 10.22%
97,745 Common Stock
Jan 19 2024
SELL
Open market or private sale
$31,086 $3.48 p/Share
8,933 Reduced 7.58%
108,867 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
91,000 Added 43.58%
117,800 Common Stock
Jan 17 2023
BUY
Grant, award, or other acquisition
-
26,800 Added 50.0%
26,800 Common Stock

Also insider at

XFOR
X4 Pharmaceuticals, Inc Healthcare
Chief Legal Officer
DMM

Derek M Meisner

Chief Legal Officer & Corp Sec
Boston, MA

Track Institutional and Insider Activities on ABOS

Follow Acumen Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABOS shares.

Notify only if

Insider Trading

Get notified when an Acumen Pharmaceuticals, Inc. insider buys or sells ABOS shares.

Notify only if

News

Receive news related to Acumen Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABOS